Vir

formerly Vir Biotechnology

Vir is a biotech company in San Francisco, United States, founded in 2016. It has raised $250.0M across 2 rounds, most recently a $250.0M Growth Equity in October 2024.

Powering the Immune System to Transform Lives

Employees
201–500
Founded
2016
Business Model
B2B
Website
vir.bio
Total Funding
$250.0M
Last Round
$250.0M Growth EquityOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Vir Biotechnology leverages the immense potential of the immune system to address critical unmet medical needs and improve patient outcomes. Its pipeline is built on two technology platforms — a next-generation antibody platform and the PRO-XTEN protease-releasable masking technology — applied to infectious diseases and oncology. The company has broken ground in immunology, engineering antibody-based medicines for COVID-19 and Ebola, with a leading program in chronic hepatitis delta and strategic programs in oncology.

Summary

It lists 201–500 employees. It has raised $250.0M in total across 2 rounds, most recently a $250.0M Growth Equity round in Oct 2024. Investors include GV and ARCH Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Secondary MarketSecondaryFeb 2026

Sign up to see all 3 events

Funding: Venture Round through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vir on Indexed.vc
<a href="https://indexed.vc/companies/vir"><img src="https://indexed.vc/api/badge/company/vir" alt="Vir on Indexed.vc" width="260" height="76" /></a>